PURPOSE: In lung cancer patients with multiple lesions, the differentiation between metastases and second primary tumours has significant therapeutic and prognostic implications. The aim of this retrospective study was to investigate the potential of (18)F-FDG PET to discriminate metastatic disease from second primary lung tumours. METHODS: Of 1,396 patients evaluated by the thoracic oncology group between January 2004 and April 2009 at the Radboud University Nijmegen Medical Centre, patients with a synchronous second primary lung cancer were selected. Patients with metastatic disease involving the lungs served as the control group. Maximum standardized uptake values (SUVs) measured with (18)F-FDG PET were determined for two tumours in each patient. The relative difference between the SUVs of these tumours (∆SUV) was determined and compared between the second primary group and metastatic disease group. Receiver-operating characteristic (ROC) curve analysis was performed to determine the sensitivity and specificity of the ∆SUV for an optimal cut-off value. RESULTS: A total of 37 patients (21 metastatic disease, 16 second primary cancer) were included for analysis. The ∆SUV was significantly higher in patients with second primary cancer than in those with metastatic disease (58 vs 28%, respectively, p < 0.001). The area under the ROC curve was 0.81 and the odds ratio for the optimal cut-off was 18.4. CONCLUSION: SUVs from (18)F-FDG PET images can be helpful in differentiating metastatic disease from second primary tumours in patients with synchronous pulmonary lesions. Further studies are warranted to confirm the consistency of these results.
PURPOSE: In lung cancerpatients with multiple lesions, the differentiation between metastases and second primary tumours has significant therapeutic and prognostic implications. The aim of this retrospective study was to investigate the potential of (18)F-FDG PET to discriminate metastatic disease from second primary lung tumours. METHODS: Of 1,396 patients evaluated by the thoracic oncology group between January 2004 and April 2009 at the Radboud University Nijmegen Medical Centre, patients with a synchronous second primary lung cancer were selected. Patients with metastatic disease involving the lungs served as the control group. Maximum standardized uptake values (SUVs) measured with (18)F-FDG PET were determined for two tumours in each patient. The relative difference between the SUVs of these tumours (∆SUV) was determined and compared between the second primary group and metastatic disease group. Receiver-operating characteristic (ROC) curve analysis was performed to determine the sensitivity and specificity of the ∆SUV for an optimal cut-off value. RESULTS: A total of 37 patients (21 metastatic disease, 16 second primary cancer) were included for analysis. The ∆SUV was significantly higher in patients with second primary cancer than in those with metastatic disease (58 vs 28%, respectively, p < 0.001). The area under the ROC curve was 0.81 and the odds ratio for the optimal cut-off was 18.4. CONCLUSION: SUVs from (18)F-FDG PET images can be helpful in differentiating metastatic disease from second primary tumours in patients with synchronous pulmonary lesions. Further studies are warranted to confirm the consistency of these results.
Authors: Miraude Adriaensen; Laura Schijf; Marie de Haas; Julia Huijbregts; Henk-Jan Baarslag; Gerald Staaks; John de Klerk Journal: Eur J Nucl Med Mol Imaging Date: 2008-08-06 Impact factor: 9.236
Authors: Se Yong Jeon; Se Han Ahn; Cheol Hyeon Kim; Sang Moo Lim; Jae Soo Koh; Jae Cheol Lee Journal: Clin Lung Cancer Date: 2008-07 Impact factor: 4.785
Authors: P P Leong; B Rezai; W M Koch; A Reed; D Eisele; D J Lee; D Sidransky; J Jen; W H Westra Journal: J Natl Cancer Inst Date: 1998-07-01 Impact factor: 13.506
Authors: H-J Jeong; J-J Min; J M Park; J-K Chung; B T Kim; J M Jeong; D S Lee; M C Lee; S K Han; Y S Shim Journal: Nucl Med Commun Date: 2002-09 Impact factor: 1.690
Authors: Jeanette L Grant; Michael C Fishbein; Long-Sheng Hong; Kostyantyn Krysan; John D Minna; Jerry W Shay; Tonya C Walser; Steven M Dubinett Journal: Cancer Prev Res (Phila) Date: 2013-11-19
Authors: Jose Arimateia Batista Araujo-Filho; Jason Chang; Maria Mayoral; Andrew J Plodkowski; Rocio Perez-Johnston; Stephanie Lobaugh; Junting Zheng; Valerie W Rusch; Natasha Rekhtman; Michelle S Ginsberg Journal: Lung Cancer Date: 2021-01-25 Impact factor: 5.705
Authors: Leslie E Quint; Rishindra M Reddy; Jules Lin; Douglas A Arenberg; Corey Speers; James A Hayman; Fengming P Kong; Mark B Orringer; Gregory P Kalemkerian Journal: Cancer Imaging Date: 2013-12-06 Impact factor: 3.909
Authors: Patrick Schöffski; Christophe M Deroose; Olivier Gheysens; Nele Lips; Koen Slabbaert; Ben Vancleynenbreugel; Philippe Moerman; Willy E Peetermans Journal: BMC Med Imaging Date: 2014-05-29 Impact factor: 1.930